Crossmark

Development of a robust stability-indicating RP-HPLC method for simultaneous estimation of triple antidiabetic combination containing dapagliflozin, gliclazide and metformin

Crossref DOI link: https://doi.org/10.1007/s44371-026-00978-x

Published Online: 2026-09-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Patel, Rajendra

Teraiya, Nishith

Prajapati, Anjali
License Information

Text and Data Mining valid from 2026-09-16

Version of Record valid from 2026-09-16
More Information

Article History

Received: 19 June 2026

Accepted: 11 September 2026

First Online: 16 September 2026

Declarations

Ethics approval and consent to participate: Not applicable.

Consent for publication: Not applicable.

Competing interests: The authors declare no competing interests.

Document is current

Any future updates will be listed below